Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Langley

Showing results (321-330 of 345) with videos related to

Pageof 35
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Vaccine|September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trialGlenn Hamonic, Elodie Pastural, Supriya Arora, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestationBarbara J Law, Joanne M Langley, Upton Allen, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccinePeyman Banooni, Bernard Gonik, Cristina Epalza, et al.
Journal of the Pediatric Infectious Diseases Society|May 4, 2023
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young ChildrenJanet A Englund, Rachel A Cohen, Veronique Bianco, et al.
Vaccine|December 24, 2021
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysisBlanché Oguti, Asad Ali, Nick Andrews, et al.
Archives of Disease in Childhood|August 21, 2021
Epidemiology, clinical features and outcomes of incident tuberculosis in children in Canada in 2013-2016: results of a national surveillance studyShaun K Morris, Ryan J P Giroux, Raquel Consunji-Araneta, et al.
The Journal of Infectious Diseases|June 7, 2022
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global SettingsJoanne M Langley, Veronique Bianco, Joseph B Domachowske, et al.
BMC Infectious Diseases|December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in CanadaMelissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Pageof 35

Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Vaccine|September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trialGlenn Hamonic, Elodie Pastural, Supriya Arora, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestationBarbara J Law, Joanne M Langley, Upton Allen, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccinePeyman Banooni, Bernard Gonik, Cristina Epalza, et al.
Journal of the Pediatric Infectious Diseases Society|May 4, 2023
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young ChildrenJanet A Englund, Rachel A Cohen, Veronique Bianco, et al.
Vaccine|December 24, 2021
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysisBlanché Oguti, Asad Ali, Nick Andrews, et al.
Archives of Disease in Childhood|August 21, 2021
Epidemiology, clinical features and outcomes of incident tuberculosis in children in Canada in 2013-2016: results of a national surveillance studyShaun K Morris, Ryan J P Giroux, Raquel Consunji-Araneta, et al.
The Journal of Infectious Diseases|June 7, 2022
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global SettingsJoanne M Langley, Veronique Bianco, Joseph B Domachowske, et al.
BMC Infectious Diseases|December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in CanadaMelissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Pageof 35